| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials
|
Messina, Carlo
|
|
2018
|
172 |
1 |
p. 9-21
|
artikel
|
| 2 |
Clinical subtypes and prognosis of pregnancy-associated breast cancer: results from the Korean Breast Cancer Society Registry database
|
Bae, Soo Youn
|
|
2018
|
172 |
1 |
p. 113-121
|
artikel
|
| 3 |
Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer
|
Kurozumi, Sasagu
|
|
2018
|
172 |
1 |
p. 61-68
|
artikel
|
| 4 |
Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy
|
Feliz-Mosquea, Yismeilin R.
|
|
2018
|
172 |
1 |
p. 69-82
|
artikel
|
| 5 |
Cost-effectiveness of monitoring endoxifen levels in breast cancer patients adjuvantly treated with tamoxifen
|
Nuland, M. van
|
|
2018
|
172 |
1 |
p. 143-150
|
artikel
|
| 6 |
De novo vitamin D supplement use post-diagnosis is associated with breast cancer survival
|
Madden, J. M.
|
|
2018
|
172 |
1 |
p. 179-190
|
artikel
|
| 7 |
Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
|
Wulaningsih, W.
|
|
2018
|
172 |
1 |
p. 167-177
|
artikel
|
| 8 |
Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors
|
Alshaker, Heba
|
|
2018
|
172 |
1 |
p. 33-43
|
artikel
|
| 9 |
Glucocorticoids in breast cancer treatment: real benefit or selection bias?
|
Guner, Gurkan
|
|
2018
|
172 |
1 |
p. 243
|
artikel
|
| 10 |
Heterogeneity of tumor cells and metastases in breast cancer patients: cause or consequence?
|
Zdravkovic, Darko
|
|
2018
|
172 |
1 |
p. 241
|
artikel
|
| 11 |
Impact of race, ethnicity, and socioeconomic factors on receipt of radiation after breast conservation surgery: analysis of the national cancer database
|
Parekh, Arti
|
|
2018
|
172 |
1 |
p. 201-208
|
artikel
|
| 12 |
Intra-tumor molecular heterogeneity in breast cancer: definitions of measures and association with distant recurrence-free survival
|
Saha, Ashirbani
|
|
2018
|
172 |
1 |
p. 123-132
|
artikel
|
| 13 |
Molecular subtypes of screen-detected breast cancer
|
Farshid, Gelareh
|
|
2018
|
172 |
1 |
p. 191-199
|
artikel
|
| 14 |
Occult breast cancer may originate from ectopic breast tissue present in axillary lymph nodes
|
Terada, Mitsuo
|
|
2018
|
172 |
1 |
p. 1-7
|
artikel
|
| 15 |
Oestrogen receptor-regulated glutathione S-transferase mu 3 expression attenuates hydrogen peroxide-induced cytotoxicity, which confers tamoxifen resistance on breast cancer cells
|
Lin, Juo-Han
|
|
2018
|
172 |
1 |
p. 45-59
|
artikel
|
| 16 |
Onco-metabolism: defining the prognostic significance of obesity and diabetes in women with brain metastases from breast cancer
|
McCall, Neal S.
|
|
2018
|
172 |
1 |
p. 221-230
|
artikel
|
| 17 |
PARP3 inhibitors ME0328 and olaparib potentiate vinorelbine sensitization in breast cancer cell lines
|
Sharif-Askari, Bahram
|
|
2018
|
172 |
1 |
p. 23-32
|
artikel
|
| 18 |
Perometry versus simulated circumferential tape measurement for the detection of breast cancer-related lymphedema
|
Sun, Fangdi
|
|
2018
|
172 |
1 |
p. 83-91
|
artikel
|
| 19 |
Population-based validation of the National Cancer Comprehensive Network recommendations for breast cancer staging
|
Abdel-Rahman, Omar
|
|
2018
|
172 |
1 |
p. 231-238
|
artikel
|
| 20 |
Pro-inflammatory cytokines and growth factors in human milk: an exploratory analysis of racial differences to inform breast cancer etiology
|
Murphy, Jeanne
|
|
2018
|
172 |
1 |
p. 209-219
|
artikel
|
| 21 |
Randomized controlled trial of weight loss versus usual care on telomere length in women with breast cancer: the lifestyle, exercise, and nutrition (LEAN) study
|
Sanft, Tara
|
|
2018
|
172 |
1 |
p. 105-112
|
artikel
|
| 22 |
Rebuttal comments on “Glucocorticoids in breast cancer treatment: Real benefit or selection bias?”
|
Lin, Ching-Hung
|
|
2018
|
172 |
1 |
p. 245
|
artikel
|
| 23 |
Screening status, tumour subtype, and breast cancer survival: a national population-based analysis
|
O’Brien, Katie M.
|
|
2018
|
172 |
1 |
p. 133-142
|
artikel
|
| 24 |
Sexual health in long-term breast cancer survivors
|
Soldera, Sara V.
|
|
2018
|
172 |
1 |
p. 159-166
|
artikel
|
| 25 |
The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer
|
Banys-Paluchowski, Malgorzata
|
|
2018
|
172 |
1 |
p. 93-104
|
artikel
|
| 26 |
The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations
|
Barnes-Kedar, Inbal
|
|
2018
|
172 |
1 |
p. 151-157
|
artikel
|
| 27 |
Towards treatment personalisation in triple negative breast cancer: role of platinum-based neoadjuvant chemotherapy
|
Rediti, Mattia
|
|
2018
|
172 |
1 |
p. 239-240
|
artikel
|
Tijdschrift beschrijving